Capricor Therapeutics
CAPR
#8197
Rank
C$0.48 B
Marketcap
C$8.31
Share price
-3.26%
Change (1 day)
-3.84%
Change (1 year)

Market capitalization of Capricor Therapeutics (CAPR)

Market cap: C$0.48 Billion

As of October 2026 Capricor Therapeutics has a market cap of C$0.48 Billion. This makes Capricor Therapeutics the world's 8197th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Capricor Therapeutics from 2002 to 2026

End of year Market Cap

Year Marketcap Change
2026C$0.48 B-77.52%
2025C$2.15 B138.19%
2024C$0.90 B351.96%
2023C$0.19 B51.06%
2022C$0.13 B46.4%
2021C$90.3 M0.35%
2020C$89.99 M929.8%
2019C$8.73 M-50.15%
2018C$17.53 M-65.68%
2017C$51.07 M-33.23%
2016C$76.49 M10.37%
2015C$69.3 M36.04%
2014C$50.94 M26%
2013C$40.43 M1838.99%
2012C$2.08 M-90.53%
2011C$22.01 M2.57%
2010C$21.46 M-37.76%
2009C$34.48 M38.17%
2008C$24.95 M-81.12%
2007C$0.13 B3660.58%
2006C$3.51 M-38.46%
2005C$5.71 M-3.07%
2004C$5.89 M18.01%
2003C$4.99 M-70.08%
2002C$16.69 M

End of Day market cap according to different sources

On Oct 25th, 2026 the market cap of Capricor Therapeutics was reported to be:

C$0.48 Billion
by Nasdaq info icon info icon
C$0.48 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
C$890.18 B 184,104.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
C$20.33 B 4,107.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Cytokinetics
CYTK
C$11.93 B 2,369.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
C$3.21 B 566.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
C$12.75 M-97.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
C$4.72 M-99.02%๐Ÿ‡บ๐Ÿ‡ธ USA